Naturalendo Tech Co., Ltd. (KOSDAQ:168330)

Market Cap	69.15B
Revenue (ttm)	22.58B
Net Income (ttm)	-3.61B
Shares Out	31.57M
EPS (ttm)	-114.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,823
Average Volume	64,253
Open	2,280.00
Previous Close	2,260.00
Day's Range	2,240.00 - 2,305.00
52-Week Range	1,262.00 - 6,300.00
Beta	0.01
RSI	37.06
Earnings Date	Nov 11, 2025

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; Seoul National University wonder, a diet ingredient; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a men...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Employees: 78
• Stock Exchange: KOSDAQ
• Ticker Symbol: 168330

Financial Performance

In 2024, Naturalendo Tech's revenue was 22.26 billion, an increase of 18.48% compared to the previous year's 18.79 billion. Losses were -3.89 billion, -11.04% less than in 2023.